Aflibercept 8 mg Provides “Greater Therapeutic Benefit” in Neovascular AMD
Compared with 2 mg, aflibercept 8 mg administered at varying intervals was more effective, with...
Read More
Meeting Coverage
Using OCTA Blood Flow Analysis to Detect Early Diabetic Retinopathy
Researchers have found a biomarker to detect early diabetic retinopathy, which involves evaluating...
Read More
Highlights from ASCO 2023 – eNSCLC
ASCO Lung Cancer Annual 2023.indd
Read More
Highlights from ASCO 2023 – HCC
ASCO HCC Annual 2023.indd
Read More
Highlights from CMSC 2023
CMSC MS Conference 2023.indd
Read More
Aflibercept 8 mg Vs 2 mg for Wet AMD: Safe & Better Outcomes
The objective of the Phase 3 PULSAR trial was to assess the efficacy and safety of intravitreal...
Read More
Varied Syringe Accuracy Affects Intravitreal Injection Safety
For a study, researchers delved into the accuracy and residual volume of commonly used syringes...
Read More
Elevating Diabetic Retinopathy Diagnosis: The Potential of OCTA Bloodflow Analysis
In a pivotal retrospective study, researchers explored the promise of quantitative bloodflow...
Read More
Promising Outcomes With Aflibercept for Diabetic Macular Edema: The PHOTON Trial
Researchers conducted a study to assess the effectiveness and safety of aflibercept at two...
Read More
ASRS Satellite Symposia
The live and hybrid satellite symposia listed below will take place in conjunction with the Annual...
Read More
ASRS Awards
ASRS Founders Award Johanna M. Seddon, MD, ScM, FARVO, FASRS, professor, interim chair and...
Read More
ASRS Schedule At A Glance
Check out the ASRS Schedule! Friday, July 28 International Symposium 1:00-2:00 PM Sub-Specialty...
Read More
Highlights From AAN 2023 – MS
AAN 2023 MS Neurov1.indd
Read More
In MS, Healthcare Inequities Based on Race & Ethnicity “Still Prevail”
In MS, Black and Hispanic patients had more trouble accessing care and reported lower-quality care...
Read More
Curative-Intent Treatment Improves Survival in Early NSCLC Regardless of Race
Curative-intent therapy in patients with early non-small cell lung cancer resulted in “nearly...
Read More
Liver Transplant Outcomes Worse for Black Patients With HCC
While liver transplantation was less likely for Black patients with HCC, those who did receive a...
Read More
Demographics Impact Time to Treatment Initiation for Patients With HCC
Hepatocellular carcinoma (HCC) comprises 75% of all liver cancer diagnoses in the United...
Read More
Greater Benefit of Adjuvant Chemo Noted in High-Risk Patients With eNSCLC
For early-stage non-small cell lung cancer (eNSCLC) surgical resection with possible adjuvant...
Read More